Orphan Drug Conference USA 2017
May 22, 2017
Orphan Drugs Conquering Rare Diseases One-by-One.
The Orphan Drug Conference USA 2017 welcomed thousands of attendees as science, industry, big pharma, and patient advocacy groups met in Washington, D.C. Their objective? To develop therapies, raise research money and bring the challenge of defeating rare diseases to the forefront. Sponsored by global events company Terrapinn, the event is in its seventh year.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.